aTYR PHARMA ATYR
NASDAQ ATYR
$0.16 -0.01 (-3.71%)
As of: Oct 23, 2026 · 1:31 PM EDT

aTYR PHARMA (ATYR) Cash from Financing Activities (2014 - 2026)

Updated

aTYR PHARMA (ATYR) recorded Cash from Financing Activities of -$129,000 in Q2 2026, compared with $17.9 million a year earlier.

Analysis

aTYR PHARMA (ATYR) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a TTM basis, aTYR PHARMA's Cash from Financing Activities came in at $29.22 million as of Jun 30, 2026, down 47.1% year-over-year; for FY2025, it came in at $66.01 million, up 65.6% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of 32.5% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $39.86 million in FY2024 (-39.8%), $66.23 million in FY2023, $5.45 million in FY2022 (-95.0%) and $110.03 million in FY2021 (+581.6%).
  • Quarterly Cash from Financing Activities has ranged from -$142,000 in Q1 2026 to $83.87 million in Q3 2021 over the past five years.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 557.3% in Q4 2023, against a decline of 97.2% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$142,000 (Q1 2026), -$131,000 (Q4 2025) and $29.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn -8.53 Bn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn -5.05 Bn
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn -3.89 Bn
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn 2.34 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -3.66 Bn
10 aTYR PHARMA 16.02 Mn -276.80 Mn - -129,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -129,000.00
Mar 31, 2026 -142,000.00
Dec 31, 2025 -131,000.00
Sep 30, 2025 29.62 Mn
Jun 30, 2025 17.90 Mn
Mar 31, 2025 18.63 Mn
Dec 31, 2024 18.84 Mn
Sep 30, 2024 -105,000.00
Jun 30, 2024 13.40 Mn
Mar 31, 2024 7.73 Mn
Dec 31, 2023 6.03 Mn
Sep 30, 2023 2.68 Mn
Jun 30, 2023 8.02 Mn
Mar 31, 2023 49.50 Mn
Dec 31, 2022 918,000.00
Sep 30, 2022 3.01 Mn
Jun 30, 2022 39,000.00
Mar 31, 2022 1.48 Mn
Dec 31, 2021 28,000.00
Sep 30, 2021 83.87 Mn
API Access

aTYR PHARMA Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ATYR&period=max&api_key=YOUR_API_KEY